Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
Launched by GROUPE HOSPITALIER SUD ILE-DE-FRANCE · Sep 24, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, taking place at Melun Hospital in France, aims to understand how well patients know their vaccination status and their attitudes towards vaccinations. Researchers want to find out how many hospitalized patients are aware of their own vaccination history and whether they would be interested in updating this information. The study also looks at how factors like gender, job, whether they have a regular doctor, and chronic illnesses may affect their knowledge and attitudes about vaccinations.
To participate, individuals need to be at least 18 years old, speak and understand French, and be currently hospitalized at Melun Hospital. Participants will be asked to fill out a questionnaire during their hospital stay, which will help researchers gather important information. This study is open to all patients, and it aims to improve understanding of vaccination awareness among hospitalized individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • French-speaking and non-demented patient : able to speak and understand French and without dementia
- • Adult patient (Age ≥ 18 years)
- • Main place of residence in France
- • Hospitalized in a department of the CH of Melun
- Exclusion Criteria :
- • Does not speak French or dementia
- • Patient's refusal to participate in the study
About Groupe Hospitalier Sud Ile De France
Groupe Hospitalier Sud Ile-de-France (GHSIF) is a prominent healthcare institution dedicated to delivering high-quality medical services and advancing clinical research in the Sud Ile-de-France region. Comprising several hospitals and healthcare facilities, GHSIF is committed to enhancing patient care through innovative research initiatives and collaborative partnerships. The organization focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to conduct clinical trials that contribute to medical knowledge and improve treatment outcomes. With a strong emphasis on patient safety and ethical standards, GHSIF plays a crucial role in the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melun, Seine Et Marne, France
Patients applied
Trial Officials
CORALIE NOEL
Principal Investigator
Groupe Hospitalier Sud Ile-de-France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported